Jennifer Ernst

About

Collaborative Leader @ intersection of neurotech, immunology, and AI. As CEO, I founded, financed, IPO-ed and eventually rebuilt Tivic (Nasdaq: TIVC) (now Valion Bio). As Chief Strategy Officer at Thin Film Electronics ASA (now Ensurge), I was part of the core team that took the company from 8 people to $480M market cap. I founded and built the company's US subsidiary, served as CEO of US subsidiary, and led acquisition, licensing, sales and marketing activities. Add to this a deep tech bkgd from PARC (now SRI), and I have a rare background that spans AI and life sciences (neurotech and immunology, devices and biologics). As founder and CEO of Tivic Health, I brought bioelectronic medicine (neuromodulation) into a new segment (respiratory). I raised $13M of private capital and $47M of public investment. I secured FDA clearance (twice) and CE Mark and took Tivic public on Nasdaq. Eventually, I made one of the hardest decisions an entrepreneur can make, to close the business line that started the company and pivoted us into a late-stage biopharmaceutical company ready to take an oncology drug to market. I licensed a Phase III asset and acquired a small CDMO to build development capab

Experience

Education